Effects of an Engineered Human Anti–TNF-α Antibody (CDP571) on Insulin Sensitivity and Glycemic Control in Patients With NIDDM
暂无分享,去创建一个
Roy Taylor | M. Sopwith | F. Ofei | S. Hurel | J. Newkirk
[1] J. Levy,et al. Type II Diabetes: Clinical Aspects of Molecular Biological Studies , 1995, Diabetes.
[2] H. Ørskov,et al. Wick Chromatography for Rapid and Reliable Immunoassay of Insulin, Glucagon and Growth Hormone , 1968, Nature.
[3] B. Spiegelman,et al. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. , 1994, The Journal of clinical investigation.
[4] K. Alberti,et al. Blood Glucose, Lactate, Pyruvate, Glycerol, 3-Hydroxybutyrate and Acetoacetate Measurements in Man Using a Centrifugal Analyser with a Fluorimetric Attachment , 1988, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.
[5] C H Lang,et al. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. , 1992, Endocrinology.
[6] Y. Ohno,et al. In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus. , 1993, The Journal of clinical endocrinology and metabolism.
[7] J. Tobin,et al. Effects of arterial versus venous sampling on analysis of glucose kinetics in man. , 1976, Journal of applied physiology.
[8] B. Parry,et al. Serum tumour necrosis factor alpha and insulin resistance in gastrointestinal cancer , 1992, The British journal of surgery.
[9] K. Alberti,et al. The Short Insulin Tolerance Test for Determination of Insulin Sensitivity: A Comparison with the Euglycaemic Clamp , 1992, Diabetic medicine : a journal of the British Diabetic Association.
[10] D. G. Jones,et al. Automated enzymatic determination of plasma free fatty acids by centrifugal analysis , 1984, The Journal of automatic chemistry.
[11] R. Bannerman,et al. Effect of pentoxifylline on carbohydrate metabolism in type II diabetics. , 1990, Archives of internal medicine.
[12] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[13] A. Nesbitt,et al. Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses. , 1995, Immunology.
[14] N. Christensen,et al. A rapid method for determination of human C-peptide in plasma. , 1991, Clinica chimica acta; international journal of clinical chemistry.
[15] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[16] M. Røder,et al. Enzyme immunoassay for intact human insulin in serum or plasma. , 1993, Clinical chemistry.
[17] M. Papa,et al. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. , 1993, The Journal of biological chemistry.
[18] J. Stephens,et al. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. , 1991, The Journal of biological chemistry.
[19] G. Kingsley,et al. The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis. , 1995, British journal of rheumatology.
[20] A. Baron,et al. Gene Expression of GLUT4 in Skeletal Muscle From Insulin-Resistant Patients With Obesity, IGT, GDM, and NIDDM , 1992, Diabetes.
[21] D. Johnston,et al. A semi-automated assay for plasma catecholamines using high-performance liquid chromatography with electrochemical detection. , 1984, Clinica chimica acta; international journal of clinical chemistry.
[22] B. Spiegelman,et al. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. , 1994, Endocrinology.